EUVIMEDEUVIMED entdecken
Crossref

Sarcopenic obesity by the ESPEN/EASO criteria for predicting mortality in advanced non-small cell lung cancer

Jinqiu Zhou, Li Luo, Lingling Xie, Song Hu, Lingling Tan, Xiaozhen Lei, Xiaozhen Luo, Ming Yang

Clinical Nutrition · 2023

DOI: 10.1016/j.clnu.2023.04.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Nutrition, 2023. Verfasst von Jinqiu Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center of Gerontology and Geriatrics, West China Hospital, Sichuan University, No. 37 Guoxue Lane, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Sarcopenia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Department of Science and Technology of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The European Society for Clinical Nutrition and Metabolism (ESPEN) and the European Association for the Study of Obesity (EASO) recently released the first international consensus on the diagnostic criteria for sarcopenic obesity (SO), which recommended skeletal muscle mass adjusted for body weight (SMM/W) to determine low muscle mass. SMM adjusted for body mass index (SMM/BMI) appeared to be better associated with physical performance than SMM/W. Thus, we modified the ESPEN/EASO criteria by using SMM/BMI. We aimed (1) to evaluate the agreement of the ESPEN/EASO-defined SO (SOESPEN) and the modified ESPEN/EASO-defined SO (SOESPEN-M) with other commonly used SO definitions, and (2) to compare different SO definitions for predicting mortality in a prospective cohort with advanced non-small cell lung cancer (NSCLC). METHODS: This prospective study included patients with advanced NSCLC. We defined SO according to five different diagnostic criteria: SOESPEN, SOESPEN-M, Asian Working Group for Sarcopenia (AWGS)-determined sarcopenia with BMI-determined obesity (SOAWGS), computed tomography-derived sarcopenia with BMI-determined obesity (SOCT), and fat mass to fat-free mass ratio >0.8 (SOFM). The outcome was all-cause mortality. RESULTS: Of the 639 participants (mean age 58.6 years, 229 women) we studied, 488 (76.4%) died during the median follow-up period of 25 months. SMM/BMI was significantly lower in the death group than in the survivor group (men: p = 0.001, women: p < 0.001), but SMM/W was not. Only 3 (0.47%) participants met all five SO diagnostic criteria. SOESPEN showed an excellent agreement with SOESPEN-M (Cohen's kappa = 0.896), a moderate agreement with SOAWGS (Cohen's kappa = 0.415), but poor agreements with SOCT and SOFM (Cohen's kappa = 0.078 and 0.092, respectively). After full adjustment for potential confounders, SOESPEN (HR 1.54, 95% CI 1.26-1.89), SOESPEN-M (HR 1.56, 95% CI 1.26-1.92), and SOAWGS (HR 1.43, 95% CI 1.14-1.78) were significantly associated with mortality. However, SOCT (HR 1.17, 95% CI 0.87-1.58) and SOFM (HR 1.15, 95% CI 0.90-1.46) showed no significant association with mortality. CONCLUSIONS: SOESPEN showed an excellent agreement with SOESPEN-M, a moderate agreement with SOAWGS, but poor agreements with SOCT and SOFM. SOESPEN, SOESPEN-M, and SOAWGS were independent prognostic factors for mortality in our study population, but SOCT and SOFM were not. Although SMM/BMI was better associated with survival than SMM/W, SOESPEN-M did not show an advantage in predicting survival over SOESPEN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaCarcinoma, Non-Small-Cell LungLung NeoplasmsMaleHumansFemaleMiddle AgedProspective StudiesBody CompositionObesityBody Mass Index

Stichwörter der Autor:innen

Muscle wastingNutritionObese sarcopeniaObesitySurvival

Autor:innen und Institutionen

  • Center of Gerontology and Geriatrics, West China Hospital, Sichuan University, No. 37 Guoxue Lane, Chengdu, Sichuan, China.
  • Center of Gerontology and Geriatrics, West China Hospital, Sichuan University, No. 37 Guoxue Lane, Chengdu, Sichuan, China; Department of Oncology, Shangjin Nanfu Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Department of Radiology, Shangjin Nanfu Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Department of Oncology, Shangjin Nanfu Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Center of Gerontology and Geriatrics, West China Hospital, Sichuan University, No. 37 Guoxue Lane, Chengdu, Sichuan, China; Precision Medicine Research Center, West China Hospital, Sichuan University, No. 37 Guoxue Lane…

Förderung

  • Department of Science and Technology of Sichuan Province

Zitieren

APA

Zhou, J., Luo, L., Xie, L., Hu, S., Tan, L., Lei, X., Luo, X., & Yang, M. (2023). Sarcopenic obesity by the ESPEN/EASO criteria for predicting mortality in advanced non-small cell lung cancer. Clinical Nutrition. https://doi.org/10.1016/j.clnu.2023.04.010

Vancouver

Zhou J, Luo L, Xie L, Hu S, Tan L, Lei X, et al. Sarcopenic obesity by the ESPEN/EASO criteria for predicting mortality in advanced non-small cell lung cancer. Clinical Nutrition. 2023. doi:10.1016/j.clnu.2023.04.010

BibTeX
@article{Zhou2023,
  author = {Zhou, Jinqiu and Luo, Li and Xie, Lingling and Hu, Song and Tan, Lingling and Lei, Xiaozhen and Luo, Xiaozhen and Yang, Ming},
  title = {Sarcopenic obesity by the ESPEN/EASO criteria for predicting mortality in advanced non-small cell lung cancer},
  journal = {Clinical Nutrition},
  year = {2023},
  doi = {10.1016/j.clnu.2023.04.010}
}
Kostenlos starten →